After completing my residency, my wife and I desired to move back to North Carolina. We enjoy spending time outdoors with our three boys, particularly mountain biking.
John H. Heinzerling, MD
About Dr. Heinzerling
"I have always enjoyed the advancing technology that radiation therapy provides to more accurately treat tumors with higher precision, often sparing patients the burden of more invasive therapies. It is a privilege to serve patients and their families during a difficult life circumstance."
Dr. Heinzerling
Professional Organizations
American Society of Therapeutic Radiology and Oncology
American College of Radiology
Association of Residents in Radiation Oncology
American Society of Clinical Oncology
American Medical Association
American Brachytherapy Society
Texas Radiological Society
Awards & Affiliations
Education
University of Texas MD Anderson Cancer Center
2011
Houston, TX
Department of Radiation Oncology Clinical Prostate Brachytherapy Elective, Dr. Steven J. Frank
University of Texas Southwestern Medical Center
2011-2012
Dallas, TX
Department of Radiation Oncology
Chief Resident, Radiation Oncology
Carilion Clinic, Carilion Memorial Hospital
Roanoke, VA
Transitional Year Resident (PGY 1)
University of Texas Southwestern Medical School
Dallas, TX
M.D. Honors: Class Rank 1 out of 234
Chubb Scholarship Award winner for outstanding medical student
Alpha Omega Alpha
Wake Forest University
Winston-Salem, NC
BA in Chemistry, Minor in Spanish and Biology
Honors: Cum Laude
Employment
SERO
Charlotte, NC
Publications
Find Dr. Heinzerling’s full list of publications on PubMed here.
- Heinzerling JH, Bland R, Mansour JC, Schwarz RE, Ramirez E, Ding C, Abdulrahman R, Boike TP, Solberg T, Timmerman RD, Meyer JJ. Dosimetric and motion analysis of margin-internsive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer. Radiation Oncology 2011 Oct; 6:1462.
- Timmerman R, Heinzerling J, Abdulrahman R, Choy H, Meyer JL. Stereotactic body radiation therapy for thoracic cancers: recommendations for patient selection, setup, and therapy. Front Radiat Ther Oncol 2011 May; 43:395-411
- Heinzerling JH, Kavanaugh B, Timmerman RD. Stereotactic ablative radiation therapy for primary lung tumors. Cancer J. 2011 Jan-Feb 17(1):28-32
- Heinzerling JH, Choy H, Hughes RD, et al. Toxicity and response of pemetrexed plus carboplatin or cisplatin with concurrent chest radiation therapy for patients with locally advanced non-small cell lung cancer: a phase I trial. Journal of Thoracic Oncology 2010 Sep 5(9):
- Heinzerling JH, Choy H. Concurrent chemoradiation alone for stage III NSCLC: is adjuvant chemotherapy necessary? The American Journal of Hematology Oncology 2009 Jul; 8(7): 335-6.
- Heinzerling JH, Papiez, L, Chien S, Anderson J, Forster K, Zhang G, Timmerman R. Stereotactic body radiation therapy: evaluation of setup accuracy and targeting methods for a new couch integrated immobilization system. Technology in Cancer Research and Treatment 2008 Jun;7(3):197-206
- Heinzerling JH, Anderson JF, Papiez L, Boike T, Chien S, Zhang, G, Abdulrahman R, Timmerman R. 4DCT scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. International Journal of Radiation Oncology, Biology, and Physics 2008 Apr 1;70(5):1571-8.
- Huerta S, Heinzerling JH, Anguiano-Hernandez YM, Huerta-Yepez S, Lin J, Chen D, Bonavida B, Livingston EH. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF. The Journal of Surgical Research. 2007 Sep; 142(1): 184-94
- Sidiqqui A, Heinzerling J, Livingston EH, Huerta S. Predictors of early mortality in veteran patients with pancreatic cancer. The American Journal of Surgery. 2007 Sep; 194(3): 362-6
- Heinzerling JH, Anthony T, Livingston EH, Huerta S. Predictors of distant metastasis and mortality in patients with stage II colorectal cancer. The American Surgeon 2007 Mar; 73(3): 230-8.
- Heinzerling JH, Huerta S. Bowel Perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management. Current Surgery 2006; 63(5): 334-337
Selected Meeting Presentations
- Heinzerling JH, Anderson JF, Papiez L, Boike T, Chien S, Zhang, G, Abdulrahman R, Timmerman R. 4D CT scan analysis of tumor and organ motion at varying levels of abdominal compression during stereotactic treatment of lung and liver. Abstract Oral Presentation: American Society for Therapeutic Radiology and Oncology Annual Meeting: November 2007
- Heinzerling JH, Hughes RS, Govindan R, Bradley JD, Peng G, Treat J, Obasaju C, Tran T, and Choy H. Toxicity and response of pemetrexed plus carboplatin or cisplatin with concurrent chest radiation therapy for patients with locally advanced non-small-cell lung cancer. Abstract Oral Presentation: American Society for Therapeutic Radiology and Oncology Annual Meeting: November 2009
Abstracts
- Anderson JF, Boike T, Heinzerling JH, Papiez L, Pistenmaa D, Timmerman RD. Assessing the feasibility of cone-Beam CT simulation for prophylaxis of heterotopic ossification following hip surgery. International Journal of Radiation Oncology, Biology, and Physics 2007 Nov 1;75(3S):S28.
- Rule W, Boike T, Cho L, Abdulrahman R, Heinzerling JH, Perkins A, Foster R, Nedzi L, Timmerman R. A phase I dose escalation study of stereotactic body radiation therapy for patients with hepatic metastases-evidence of a dose-response relationship. International Journal of Radiation Oncology, Biology, and Physics 2009 Nov 1;75(3S):S28.
- Derose PM, Boike T, Heinzerling JH, Abdulrahman R, Spangler A, Choy H, Tripathy D, Garwood D. Toxicity of concurrent capecitabine and external beam irradiation in the adjuvant treatment of high risk breast cancer: a phase II trial. International Journal of Radiation Oncology, Biology, and Physics 2009 Nov 1;75(3S):S187.
- Heinzerling JH, Hughes RS, Govindan R, Bradley JD, Schiller J, Peng G, Treat J, Obasaju C, Tran T, Choy H. A phase I study of pemetrexed plus carboplatin or cisplatin with
concurrent chest radiation therapy for patients with locally advanced non-small cell lung cancer. Journal of Clinical Oncology 2009 May 20;27(15S):393s. - Anderson JF, Heinzerling JH, Mao W, Papiez L, Abdulrahman R, Choy H, Solberg T, Timmerman R. 4D cone beam CT to assess daily variation of respiratory motion after abdominal compression in lung SBRT. International Journal of Radiation Oncology, Biology, and Physics 2009 Nov 1;75(3S):S635.
- Heinzerling JH, Ding C, Ramirez E, Chang K, Anderson JF, Edwards CM, Boike T, Rule W, Solberg T, Timmerman RD. Comparative Dose-Volume Analysis for Cyberknife and 3D Conformal Partial Breast Irradiation Treatment of Early Stage Breast Cancer. Abstract Poster Presentation: American Society for Therapeutic Radiology and Oncology Annual Meeting: November 2010
- Rule WG, Jiang L, Boike T, Anderson J, Jain S, Heinzerling J, DeRose P, Edwards M, Tong L, Solberg T. A Dosimetric Comparison of Prostate Plans: IMRT, SmartArc, RapidArc And HybridArc. Abstract Poster Presentation: American Society for Therapeutic Radiology and Oncology Annual Meeting: November 2010
- Jiang L, Li H, Heinzerling JH, Boike T, Solberg TD, Foster RD. Dosimetric evaluation of margin reduction and intrafraction motion for prostate SBRT. Abstract Poster Presentation: ESTRO 11th Biennial Physics Meeting: May 2011
- Heinzerling JH, Timmerman C, Zhao H, Ramirez E, Ding C, Foster RD, Solberg T, Timmerman RD. Comparative dose-volume analysis for fractionated radiotherapy of central brain tumors in pediatric patients using Cyberknife, IMRT, and BrainLab. Abstract Poster Presentation: ESTRO 11th Biennial Physics Meeting: May 2011
- Heinzerling JH, Jiang L, Hong DS, Li H, Foster RD, Anderson JF, Solberg TD, Boike T. Intrafraction Motion and Dosimetric Evaluation of Margin Reduction During Fractionated Rapid Arc Treatment of Prostate Cancer. Abstract Poster Presentation: 2011 Joint AAPM/COMP Meeting July 2011
- Jiang L, Li H, Heinzerling JH, Boike T, Solberg, TD, Foster RD. Dosimetric Evaluation of PTV Margins and Intrafraction Motion for Prostate SBRT. Abstract Poster Presentation: 2011 Joint AAPM/COMP Meeting July 2011
Protocol Development
- Role: Co- Investigator
Title: Phase I study of margin-intense combination therapy for patients with potentially resectable
pancreatic adenocarcinoma
Duration: 8/2008-2012
Status: Closed to accrual - Role: Co- Investigator
Title: Phase I Study of Cyberknife® Partial Breast Irradiation
(PBI) for Early Stage Breast Cancer
Duration: 7/2009-present
Status: Open for accrual - Role: Co- Investigator
Title: Phase III Randomized Study of Standard versus
Accelerated Hypofractionated Image-Guided Radiation
Therapy (IGRT) in Patients with Stage II-IV Non-Small Cell
Lung Cancer and Poor Performance Status
Duration: 3/2011-present
Status: Pending IRB approval